Recent developments in protein and cell-targeted aptamer selection and applications

Current Medicinal Chemistry

Volumn 18, Issue 27, 2011, Pages 4117-4125

  Liu, Jun ^a,c   You, Mingxu ^c   Pu, Ying ^a,c   Liu, Huixia ^a   Ye, Mao ^b   Tan, Weihong ^b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN UNIVERSITY   (China)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Aptamer; Biomarker discovery; Detection; Drug delivery; Imaging; Molecular probe; SELEX; Visualization

Indexed keywords

ANTINEOPLASTIC AGENT; APTAMER; BIOLOGICAL MARKER; CELL SURFACE PROTEIN; FLUORESCENT DYE; FLUORODEOXYGLUCOSE F 18; HISTONE; PROTEIN; PROTEIN TYROSINE KINASE 7; RNA; SINGLE STRANDED DNA; TRANSFERRIN; UNCLASSIFIED DRUG;

B CELL LYMPHOMA; BINDING AFFINITY; CANCER CELL; CANCER DIAGNOSIS; CANCER INHIBITION; CAPILLARY ELECTROPHORESIS; CELL ASSAY; CELL LINE; CELL MEMBRANE; CELL VIABILITY; CHEMICAL MODIFICATION; COMBINATORIAL CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; CYTOTOXICITY; DIAGNOSTIC ACCURACY; DNA BINDING; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG STABILITY; EARLY DIAGNOSIS; FLOW CYTOMETRY; GEL ELECTROPHORESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; INFECTION; LEUKEMIA CELL; METASTASIS; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN ISOLATION; PROTEIN MODIFICATION; PROTEIN TARGETING; REVIEW; SENSITIVITY AND SPECIFICITY;

ANIMALS; APTAMERS, NUCLEOTIDE; CELLS; HUMANS; PROTEINS; SELEX APTAMER TECHNIQUE;

EID: 80052208951     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711797189619     Document Type: Review

References (105)

1. Osborne, S.E.; Matsumura, I.; Ellington, A.D. Aptamers as therapeutic and diagnostic reagents: problems and prospects. Curr. Opin. Chem. Biol., 1997, 1(1), 5-9. (Pubitemid 127435139)
2. Famulok, M.; Hartig, J.S.; Mayer, G. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. Chem. Rev., 2007, 107(9), 3715-3743. (Pubitemid 47534316)
3. Navani, N.K.; Li, Y. Nucleic acid aptamers and enzymes as sensors. Curr. Opin. Chem. Biol., 2006, 10(3), 272-281. (Pubitemid 43815779)
4. Bunka, D.H.; Stockley, P.G. Aptamer come of age - at last. Nat. Rev. Microbiol., 2006, 4(8), 588-596.
5. Ellington, A.D.; Szostak, J.W. In vitro selection of RNA molecules that bind specific ligands. Nature, 1990, 346(6287), 818-822.
6. Tuerk, C.; Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science, 1990, 249(4968), 505-510.
7. Green, L.S.; Jellinek, D.; Bell, C.; Beebe, L.A.; Feistner, B.D.; Gill, S.C.; Jucker, F.M.; Janjic, N. Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. Chem. Biol., 1995, 2(10), 683-695.
8. Gold, L.; Polisky, B.; Uhlenbeck, O.; Yarus, M. Diversity of oligonucleotide functions. Annu. Rev. Biochem., 1995, 64, 763-797.
9. Jiang, Y.; Zhu, C.; Ling, L.; Wan, L.; Fang, X.; Bai, C. Specific aptamerprotein interaction studied by atomic force microscopy. Anal. Chem., 2003, 75(9), 2112-2116. (Pubitemid 36542352)
10. Masud, M.M.; Kuwahara, M.; Ozaki, H.; Sawai, H. Sialyllactose-binding modified DNA aptamer bearing additional functionality by SELEX. Bioorg. Med. Chem., 2004, 12(5), 1111-1120. (Pubitemid 38251302)
11. Vaish, N.K.; Larralde, R.; Fraley, A.W.; Szostak, J.W.; McLaughlin, L.W. A novel, modification-dependent ATP-binding aptamer selected from an RNA library incorporating a cationic functionality. Biochemistry, 2003, 42(29), 8842-8851. (Pubitemid 36899828)
12. Pagratis, N.C.; Bell, C.; Chang, Y.F.; Jennings, S.; Fitzwater, T.; Jellinek, D.; Dang, C. Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inibitors of keratinocyte growth factor. Nat. Biotechnol., 1997, 15(1), 68-73.
13. Chelliserrykattil, J.; Ellington, A.D. Evolution of a T7 RNA polymerase variant that transcribes 2′-O-methyl RNA. Nat. Biotechnol., 2004, 22(9), 1155-1160. (Pubitemid 39166855)
14. The Eyetech Study Group. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative agerelated macular degeneration. Retina, 2002, 22(2), 143-152.
15. Khati, M. The future of aptamers in medicine. J. Clin. Pathol., 2010, 63(6), 480-487.
16. The Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology, 2003, 110(5), 979-986.
17. Lopes de Campos, W.R.; Coopusamy, D.; Morris, L.; Mayosi, B.M.; Khati, M. Cytotoxicological analysis of a gp120 binding aptamer with cross-clade human immunodeficiency virus type 1 entry inhibition properties: comparison to conventional antiretrovirals. Antimicrob. Agents Chemother., 2009, 53(7), 3056-3064.
18. Marshall, K.A.; Ellington, A.D. In vitro selection of RNA aptamers. Methods Enzymol., 2000, 318, 193-214.
19. Shangguan, D.; Li, Y.; Tang, Z.; Cao, Z.C.; Chen, H.W.; Mallikaratchy, P.; Sefah, K.; Yang, C.J.; Tan, W. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc. Natl. Acad. Sci. USA, 2006, 103(32), 11838-11843. (Pubitemid 44215773)
20. Bock, L.C.; Griffin, L.C.; Latham, J.A.; Vermaas, E.H.; Toole, J.J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature, 1992, 355(6360), 564-566.
21. Muller, J.; Wulffen, B.; Potzsch, B.; Mayer, G. Multidomain targeting generates a high-affinity thrombin-inhibiting bivalent aptamer. ChemBioChem, 2007, 8(18), 2223-2226.
22. Kim, Y.; Cao, Z.; Tan, W. Molecular assembly for high-performance bivalent nucleic acid. Proc. Natl. Acad. Sci. USA, 2008, 105(15), 5664-5669. (Pubitemid 351758428)
23. Jayasena, S.D. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin. Chem., 1999, 45(9), 1628-1650. (Pubitemid 29419030)
24. Kopylov, A.M.; Spiridonova, V.A., Combinatorial chemistry of nucleic acids: SELEX. Mol. Biol. (Mosk), 2000, 34(6), 1097-1113.
25. Kusser, W. Chemically modified nucleic acid aptamers for in vitro selections: evolving evolution. J. Biotechnol., 2000, 74(1), 27-38.
26. Burmeister, P.E.; Lewis, S.D.; Silva, R.F.; Preiss, J.R.; Horwitz, L.R.; Pendergrast, P.S.; McCauley, T.G.; Kurz, J.C.; Epstein, D.M.; Wilson, C.; Keefe, A.D. Direct in vitro selection of a 2′-O-methyl aptamer to VEGF. Chem. Biol., 2005, 12(1), 25-33. (Pubitemid 40118323)
27. Gopinath, S.C. Methods developed for SELEX. Anal. Bioanal. Chem., 2007, 387(1), 171-182. (Pubitemid 44956270)
28. Stoltenburg, R.; Reinemann, C.; Strehlitz, B. SELEX-a revolutionary method to generate high-affinity nucleic acid ligands. Biomol. Eng., 2007, 24(4), 381-403. (Pubitemid 47391579)
29. Tracy, R.B.; Kowalczykowski, S.C. In vitro selection of preferred DNA pairing sequences by the Escherichia coli RecA protein. Genes. Dev., 1996, 10(15), 1890-1903. (Pubitemid 26281684)
30. Smith, D.; Kirschenheuter, G.P.; Charlton, J.; Guidot, D.M.; Repine, J.E. In vitro selection of RNA-based inhibitors of human neotrophil elastase. Chem.Biol., 1995, 2(11), 741-750.
31. Goodman, S.D.; Velten, N.J.; Gao, Q.; Robinson, S.; Segall, A.M. In vitro selection of integration host factor binding sites. J. Bacteriol., 1999, 181(10), 3246-3255. (Pubitemid 29236933)
32. Hicke, B.J.; Marion, C.; Chang, Y.F.; Gould, T.; Lynott, C.K.; Parma, D.; Schmidt, P.G.; Warren, S. Tenascin-C aptamers are generated using tumor cells and purified protein. J. Biol. Chem., 2001, 276(52), 48644-48654.
33. Rhodes, A.; Deakin, A.; Spaull, J.; Coomber, B.; Aitken, A.; Life, P.; Rees, S. The generation and characterization of antagonist RNA aptamers to human oncostatin M. J. Biol. Chem., 2000, 275(37), 28555-28561.
34. Stoltenburg, R.; Reinemann, C.; Strehlitz, B. FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal. Bioanal. Chem., 2005, 383(1), 83-91. (Pubitemid 41549245)
35. Davis, K.A.; Lin, Y.; Abrams, B.; Jayasena, S.D. Staining of cell surface human CD4 with 2′-F-pyrimidine-containing RNA aptamers for flow cytometry. Nucleic Acids Res., 1998, 26(17), 3915-3924. (Pubitemid 28401340)
36. Misono, T.S.; Kumar, P.K. Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonance. Anal. Biochem., 2005, 342(2), 312-317. (Pubitemid 40884581)
37. Jensen, K.B.; Atkinson, B.L.; Willis, M.C.; Koch, T.H.; Gold, L. Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 protein to high-affinity RNA ligands. Proc. Natl. Acad. Sci. USA, 1995, 92(26), 12220-12224. (Pubitemid 26014042)
38. Golden, M.C.; Collins, B.D.; Willis, M.C.; Koch, T.H. Diagnostic potential of photoSELEX-evolved ssDNA aptamers. J. Biotechnol., 2000, 81(2-3), 167-178.
39. Mendonsa, S.D.; Bowser, M.T. In vitro evolution of functional DNA using capillary electrophoresis. J. Am. Chem. Soc., 2004, 126(1), 20-21. (Pubitemid 38090319)
40. Berezovski, M.; Drabovich, A.; Krylova, S.M.; Musheev, M.; Okhonin, V.; Petrov, A.; Krylov, S.N. Nonequilibrium capillary electrophoresis of equilibrium mixtures: a universal tool for development of aptamers. J. Am. Chem. Soc., 2005, 127(9), 3165-3171. (Pubitemid 40349896)
41. Drabovich, A.; Berezovski, M.; Krylov, S.N. Selection of smart aptamers by equilibrium capillary electrophoresis of equilibrium mixtures (ECEEM). J. Am. Chem. Soc., 2005, 127(32), 11224-11225. (Pubitemid 41176866)
42. Mendonsa, S.D.; Bowser, M.T. In vitro selection of aptamers with affinity for neuropeptide Y using capillary electrophoresis. J. Am. Chem. Soc., 2005, 127(26), 9382-9383. (Pubitemid 40934747)
43. Mosing, R.K.; Mendonsa, S.D.; Bowser, M.T. Capillary electrophoresis- SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal. Chem., 2005, 77(19), 6107-6112. (Pubitemid 41436941)
44. Mallikaratchy, P.; Stahelin, R.V.; Cao, Z.; Cho, W.; Tan, W. Selection of DNA ligands for protein kinase C- δ. Chem. Commun., 2006, (30), 3229-3231. (Pubitemid 44126575)
45. Williams, B.A.; Lin, L.; Lindsay, S.M.; Chaput, J.C. Evolution of a histone H4-K16 acetyl-specific DNA aptamer. J. Am. Chem. Soc., 2009, 131(18), 6330-6331.
46. Tran, D.T.; Janssen, K.P.; Pollet, J.; Lammertyn, E.; Anne, J.; Van Schepdael, A.; Lammertyn, J. Selection and characterization of DNA aptamers for egg white lysozyme. Molecules, 2010, 15(3), 1127-1140.
47. Tok, J.; Lai, J.; Leung, T.; Li, S.F. Selection of aptamers for signal transduction proteins by capillary electrophoresis. Electrophoresis, 2010, 31(12), 2055-2062.
48. Lou, X.; Qian, J.; Xiao, Y.; Viel, L.; Gerdon, A.E.; Lagally, E.T.; Atzberger, P.; Tarasow, T.M.; Heeger, A.J.; Soh, H.T. Micromagnetic selection of aptamersin microfluidic channels. Proc. Natl. Acad. Sci. USA, 2009, 106(9), 2989-2994.
49. Qian, J.; Lou, X.; Zhang, Y.; Xiao, Y.; Soh, H.T. Generation of highly specific aptamers via micromagnetic selection. Anal. Chem., 2009, 81(13), 5490-5495.
50. Cox, J.C.; Ellington, A.D. Automated selection of anti-protein aptamers. Bioorg. Med. Chem., 2001, 9(10), 2525-2531. (Pubitemid 32824154)
51. Cox, J.C.; Hayhurst, A.; Hesselberth, J.; Bayer, T.S.; Georgiou, G.; Ellington, A.D. Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer. Nucleic Acids Res., 2002, 30(20), e108.
52. Eulberg, D.; Buchner, K.; Maasch, C.; Klussmann, S. Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of biostable substance P antagonist. Nucleic Acids Res., 2005, 33(4), e45.
53. Daniels, D.A.; Chen, H.; Hicke, B.J.; Swiderek, K.M.; Gold, L. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment. Proc. Natl. Acad. Sci. USA, 2003, 100(26), 15416-15421. (Pubitemid 38021004)
54. Cerchia, L.; Duconge, F.; Pestourie, C.; Boulay, J.; Aissouni, Y.; Gombert, K.; Tavitian, B.; de Franciscis, V.; Libri, D. Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol., 2005, 3(4), e123.
55. Shamah, S.M.; Healy, J.M.; Cload, S.T. Complex target SELEX. Acc. Chem. Res., 2008, 41(1), 130-138.
56. Blank, M.; Weinschenk, T.; Priemer, M.; Schluesener, H. Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. J. Biol. Chem., 2001, 276(19), 16464-16468.
57. Berezovski, M.V.; Lechmann, M.; Musheev, M.U.; Mak, T.W.; Krylov, S.N. Aptamer-facilitated biomarker discovery (AptaBiD). J. Am. Chem. Soc., 2008, 130(28), 9137-9143. (Pubitemid 352000854)
58. Guo, K.T.; SchAfer, R.; Paul, A.; Gerber, A.; Ziemer, G.; Wendel, H.P. A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers. Stem Cells, 2006, 24(10), 2220-2231. (Pubitemid 44527475)
59. Raddatz, M.S.; Dolf, A.; Endl, E.; Knolle, P.; Famulok, M.; Mayer, G. Fluorescent-activated cell sorting enriches cell-targeting and populationspecific aptamers. Angew. Chem. Int. Ed. Engl., 2008, 47(28), 5190-5193.
60. Sefah, K.; Tang, Z.W.; Shangguan, D.H.; Chen, H.; Lopez-Colon, D.; Li, Y.; Parekh, P.; Martin, J.; Meng, L.; Phillips, J.A.; Kim, Y.M.; Tan, W.H. Molecular recognition of acute myeloid leukemia using aptamers. Leukemia, 2009, 23(2), 235-244.
61. Chen, H.W.; Medley, C.D.; Sefah, K.; Shangguan, D.; Tang, Z.; Meng, L.; Smith, J.E.; Tan, W. Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem, 2008, 3(6), 991-1001.
62. Tang, Z.; Shangguan, D.; Wang, K.; Shi, H.; Sefah, K.; Mallikratchy, P.; Chen, H.W.; Li, Y.; Tan, W. Selection of aptamers for molecular recognition and characterization of cancer cells. Anal. Chem., 2007, 79(13), 4900-4907. (Pubitemid 47051443)
63. Fang, X.; Tan, W. Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc. Chem. Res., 2010, 43(1), 48-57.
64. Sefah, K.; Shangguan, D.; Xiong, X.; O'Donoghue, M.B.; Tan, W. Development of DNA aptamers using cell-SELEX. Nat. Protoc., 2010, 5(6), 1169-1185.
65. Parekh, P.; Tang, Z.; Turner, P.C.; Moyer, R.W.; Tan, W. Aptamers recognize glycosylated Hemagglutinin expressed on the surface of vaccinia virus infected cells. Anal. Chem., 2010, 82(20), 8642-8649.
66. Liu, J.; Yang, Y.; Hu, B.; Ma, Z.Y.; Huang, H.P.; Yu, Y.; Liu, S.P.; Lu, M.J.; Yang, D.L. Development of HBsAg-binding aptamers that bind HepG2.2.15 cells via HBV surface antigen. Virol. Sin., 2010, 25(1), 27-35.
67. Shangguan, D.; Cao, Z.C.; Li, Y.; Tan, W. Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples. Clin. Chem., 2007, 53(6), 1153-1155. (Pubitemid 46867534)
68. Van Simaeys, D.; López-Colón, D.; Sefah, K.; Sutphen, R.; Jimenez, E.; Tan, W. Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX. PLoS One, 2010, 5(11), e13770.
69. Tang, Z.; Parekh, P.; Turner, P.; Moyer, R.W.; Tan, W. Generating aptamers for recognition of virus-infected cells. Clin. Chem., 2009, 55(4), 813-822.
70. Hamula, C.L.; Zhang, H.; Guan, L.L.; Li, X.F.; Le, X.C. Selection of aptamers against live bacterial cells. Anal. Chem., 2008, 80(20), 7812-7819.
71. Chen, F.; Zhou, J.; Luo, F.; Mohammed, A.B.; Zhang, X.L. Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent mycobacterium tuberculosis. Biochem. Biophys. Res. Commun., 2007, 357(3), 743-748. (Pubitemid 46653843)
72. Nitsche, A.; Kurth, A.; Dunkhorst, A.; Panke, O.; Sielaff, H.; Junge, W.; Muth, D.; Scheller, F.; Stocklein, W.; Dahmen, C.; Pauli, G.; Kage, A. Onestep selection of vaccinia virus-binding DNA aptamers by monoLEX. BMC Biotechnol., 2007, 7, 48.
73. Mallikaratchy, P.; Tang, Z.; Kwame, S.; Meng, L.; Shangguan, D.; Tan, W. Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy Mu chain in burkitt's lymphoma cells. Mol. Cell. Proteomics, 2007, 6(12), 2230-2238.
74. Mi, J.; Liu, Y.; Rabbani, Z.N.; Yang, Z.; Urban, J.H.; Sullenger, B.A.; Clary, B.M. In vivo selection of tumor-targeting RNA motifs. Nat. Chem. Biol., 2010, 6(1), 22-24.
75. Yang, X.; Li, T.; Li, B.; Wang, E. Potassium-sensitive G-quadruplex DNA for sensitive visible potassium detection. Analyst, 2010, 135(1), 71-75.
76. Gopinath, S.C.; Sakamaki, Y.; Kawasaki, K.; Kumar, P.K. An efficient RNA aptamer against human influenza B virus hemagglutinin. J. Biochem., 2006, 139(5), 837-846. (Pubitemid 44014577)
77. Balogh, Z.; Lautner, G.; Bardoczy, V.; Komorowska, B.; Gyurcsanyi, R.E.; Meszaros, T., Selection and versatile application of virus-specific aptamers. FASEB J., 2010, 24(11), 4187-4195.
78. Wu, C.C.; Yates, J.R. The application of mass spectrometry to membrane proteomics. Nat. Biotechnol., 2003, 21(3), 262-267. (Pubitemid 36314809)
79. Shangguan, D.; Meng, L.; Cao, Z.C.; Xiao, Z.; Fang, X.; Li, Y.; Cardona, D.; Witek, R.P.; Liu, C.; Tan, W. Identification of liver cancer-specific aptamers using whole live cells. Anal. Chem., 2008, 80(3), 721-728. (Pubitemid 351206860)
80. Massoud, T.F.; Paulmurugan, R.; Gambhir, S.S. Molecular imgaing of homodimeric protein-protein interactions in living subjects. FASEB J., 2004, 18(10), 1105-1107. (Pubitemid 39561538)
81. Zhong, H.; Zhang, Q.; Zhang, S. High-Intensity Fluorescence Imaging and Sensitive Electrochemical Detection of Cancer Cells by using an Extracellular Supramolecular Reticular DNA-Quantum Dot Sheath. Chem. Eur. J. 2011, 17(30), 8388-8394.
82. Shi, H.; Tang, Z.; Kim, Y.; Nie, H.; Huang, Y.F.; He, X.; Deng, K.; Wang, K.; Tan, W. In vivo fluorescence imaging of tumors using molecular aptamers generated by cell-SELEX. Chem. Asian J., 2010, 5(10), 2209-2213.
83. Rockey, W.M.; Huang, L.; Kloepping, K.C.; Baumhover, N.J.; Giangrande, P.H.; Schultz, M.K. Syntheis and radiolabeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging. Bioorg. Med. Chem., 2011, 19(13), 4080-4090.
84. Yu, M.K.; Kim, D.; Lee, I.H.; So, J.S.; Jeong, Y.Y.; Jon, S. Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles. Small, 2011, DOI 10.1002/smll.201100472.
85. Sefah, K.; Meng, L.; Lopez-Colon, D.; Jimenez, E.; Liu, C.; Tan, W. DNA aptamers as molecular probes for colorectal cancer study. PLoS One, 2010, 5(12), e14269.
86. Xiao, Z.; Shangguan, D.; Cao, Z.; Fang, X.; Tan, W. Cell-specific internalization study of an aptamer from whole cell selection. Chem. Eur. J. 2008, 14(6), 1769-1775.
87. Negm, R.S.; Verma, M.; Srivastava, S. The promise of biomarkers in cancer screening and detection. Trends Mol. Med., 2002, 8(6), 288-293. (Pubitemid 34568384)
88. Smith, J.E.; Medley, C.D.; Tang, Z.; Shangguan, D.; Lofton, C.; Tan, W. Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. Anal. Chem., 2007, 79(8), 3075-3082. (Pubitemid 46640529)
89. Zhao, Z.; Xu, L.; Shi, X.; Tan, W.; Fang, X.; Shangguan, D. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. Analyst, 2009, 134(9), 1808-1814.
90. Medley, C.D.; Smith, J.E.; Tang, Z.; Wu, Y.; Bamrungsap, S.; Tan, W. Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. Anal. Chem., 2008, 80(4), 1067-1072. (Pubitemid 351272339)
91. Pu, Y.; Zhu, Z.; Liu, H.; Zhang, J.; Liu, J.; Tan, W. Using aptamers to visualize and capture cancer cells. Anal. Bioanal. Chem., 2010, 397(8), 3225-3233.
92. Wu, Y.; Sefah, K.; Liu, H.; Wang, R.; Tan, W. DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells. Proc. Natl. Acad. Sci. USA, 2010, 107(1), 5-10.
93. Wheeler, L.A.; Trifonova, R.; Vrbanac, V.; Basar, E.; McKernan, S.; Xu, Z.; Seung, E.; Deruaz, M.; Dudek, T.; Einarsson, J.I.; Yang, L.; Allen, T.M.; Luster, A.D.; Tager, A.M.; Dykxhoorn, D.M.; Lieberman, J. Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras. J. Clin. Invest., 2011, 121(6), 2401-2412.
94. McNamara, J.O., 2nd; Andrechek, E.R.; Wang, Y.; Viles, K.D.; Rempel, R.E.; Gilboa, E.; Sullenger, B.A.; Giangrande, P.H. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol., 2006, 24(8), 1005-1015. (Pubitemid 44215395)
95. Chu, T.C.; Twu, K.Y.; Ellington, A.D.; Levy, M. Aptamer mediated siRNA delivery. Nucleic Acids Res., 2006, 34(10), e73.
96. Huang, Y.F.; Shangguan, D.; Liu, H.; Phillips, J.A.; Zhang, X.; Chen, Y.; Tan, W. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem, 2009, 10(5), 862-868.
97. Ireson, C.R.; Kelland, L.R. Discovery and development of anticancer aptamers. Mol. Cancer Ther., 2006, 5(12), 2957-2962. (Pubitemid 46092036)
98. You, M.; Chen, Y.; Peng, L.; Han, D.; Yin, B.; Ye, B.; Tan, W. Engineering DNA aptamers for novel analytical and biomedical applications. Chem. Sci., 2011, 2, 1003-1010.
99. Que-Gewirth, N.S.; Sullenger, B.A., Gene therapy progress and prospects: RNA aptamers. Gene Ther., 2007, 14(4), 283-291. (Pubitemid 46231922)
100. Antisoma. Antisoma clinical development pipeline. London, UK. 2010. http://www.antisoma.com/asm/products/pipeline/
101. Regado Biosciences. Pipeline. Durham, USA. 2009. http://www. regadobiosciences.com/pipeline-clinical/pipeline.htm
102. Archemix. Product pipeline. Cambridge, USA. 2009. http://www.archemix. com/website/products.php
103. Archemix and Nuvelo close phase I trial for thrombin inhibitor. ARC183: Archemix, Cambridge, USA, 2009. http://www.archemix.com/website/-popup-press- release.php?release=17
104. Ophthotech. E10030-anti-PDGF aptamer. Princeton, USA. 2010. http://www.ophthotech.com/products/e10030/
105. Ophthotech. ARC1905-anti-C5 Aptamer. Princeton, USA. 2010. www.ophthotech.com/products/arc1905